BioCryst Pharmaceuticals | BCRX - Revenu Net





Revenu Net Changement Date
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
Chugai Pharma JPY 116.33B 913M 2026-06
Daiichi Sankyo JPY 68.64B 18B 2026-06
DBV Technologies USD -47.6M 2.77M 2026-03
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
Glaxosmithkline GBP 1.74B 890.94M 2026-03
Incyte USD 585.6M 282.27M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Novavax USD 17.53M 219.91M 2025-12
PTC Therapeutics USD -2.81M 132.16M 2026-03
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06